Records 1 - 30
| Systematic review of tumour budding and association with common mutations in patients with colorectal cancer.
Critical reviews in oncology/hematology 2021 Oct 167 103490.
Hatthakarnkul Phimmada, Quinn Jean A, Matly Amna Ahmed Mohemmd, Ammar Aula, van Wyk Hester C, McMillan Donald C, Edwards Joan
| Reevaluating the prognostic role of BRAF mutation in colorectal cancer liver metastases.
American journal of surgery 2021 Sep .
Pikouli Anastasia, Papaconstantinou Dimitrios, Wang Jane, Kavezou Foteini, Pararas Nikolaos, Nastos Constantinos, Pikoulis Emmanouil, Margonis Georgios Antoni
| KRAS and BRAF mutations in Iranian colorectal cancer patients: A systematic review and meta-analysis.
Caspian journal of internal medicine 2020 11 (4): 355-369.
Yari Abolfazl, Afzali Asiyeh, Aalipour Mostafa, Nakheai Mehran, Zahedi Mohammad Jav
| Impact of KRAS mutation status on outcomes of metastatic colorectal cancer treated with anti-angiogenic agents: a meta-analysis.
Journal of chemotherapy (Florence, Italy) 2019 Dec 1-8.
Liang Xiaojun, Shen J
| Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis.
Cancer medicine 2019 Dec .
Bylsma Lauren C, Gillezeau Christina, Garawin Tamer A, Kelsh Michael A, Fryzek Jon P, Sangaré Laura, Lowe Kimberly
| The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta-analysis of patient and study characteristics.
Cancer medicine 2019 Aug .
Bylsma Lauren C, Dean Rebecca, Lowe Kimberly, Sangaré Laura, Alexander Dominik D, Fryzek Jon
| Impact of primary colorectal Cancer location on the KRAS status and its prognostic value.
BMC gastroenterology 2019 Mar 19 (1): 46.
Xie Ming-Zhi, Li Ji-Lin, Cai Zheng-Min, Li Ke-Zhi, Hu Bang-
| Mutations of key driver genes in colorectal cancer progression and metastasis.
Cancer metastasis reviews 2018 Jan .
Huang Dongdong, Sun Wenjie, Zhou Yuwei, Li Peiwei, Chen Fang, Chen Hanwen, Xia Dajing, Xu Enping, Lai Maode, Wu Yihua, Zhang Hong
| Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis.
Cancer management and research 2018 10 2915-2924.
Chen Duke, Wu Yu-Shen, Lin Huapeng, Wang Yihan, Li Longhao, Zhang T
| Increased Frequency of KRAS Mutations in African Americans Compared with Caucasians in Sporadic Colorectal Cancer.
Clinical and translational gastroenterology 2017 Oct 8 (10): e124.
Staudacher Jonas J, Yazici Cemal, Bul Vadim, Zeidan Joseph, Khalid Ahmer, Xia Yinglin, Krett Nancy, Jung Barba
| Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer: Direct and indirect comparison meta-analysis.
Medicine 2017 Sep 96 (35): e7882.
Kwak Min Seob, Cha Jae Myung, Yoon Jin Young, Jeon Jung Won, Shin Hyun Phil, Chang Hye Jung, Kim Hyung Kyung, Joo Kwang Ro, Lee Joung
| The impact of primary tumor location on efficacy of cetuximab in metastatic colorectal cancer patients with different Kras status: a systematic review and meta-analysis.
Oncotarget 2017 (32): 53631-53641.
Cao De-Dong, Xu Hui-Lin, Xu Xi-Ming, Ge W
| Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
The oncologist 2017 Aug .
Spindler Karen-Lise G, Boysen Anders K, Pallisgård Niels, Johansen Julia S, Tabernero Josep, Sørensen Morten M, Jensen Benny V, Hansen Torben F, Sefrioui David, Andersen Rikke F, Brandslund Ivan, Jakobsen Ande
| KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.
Oncotarget 2017 Jan .
Du Lijun, Kim John J, Shen Jinhua, Chen Binrui, Dai Ni
| Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis.
OncoTargets and therapy 2017 10 945-953.
Hao Yi-Xin, Fu Qiang, Guo Yan-Yan, Ye Ming, Zhao Hui-Xia, Wang Qi, Peng Xiu-Mei, Li Qiu-Wen, Wang Ru-Liang, Xiao Wen-H
| The prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis.
PloS one 2017 12 (8): e0182562.
Zhuang Rongyuan, Li Song, Li Qian, Guo Xi, Shen Feng, Sun Hong, Liu Tians
| Evaluation and identification of factors related to KRAS and BRAF gene mutations in colorectal cancer: A meta-analysis.
Journal of cancer research and therapeutics 2016 Dec 12 (Supplement): C191-C198.
Lin Li, Chen Guang-Yong, Xu Chun-Wei, Wang Hai-Yan, Wu Yong-Fang, Fang Mei-
| Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis.
The pharmacogenomics journal 2016 Nov .
Morgen E K, Lenz H-J, Jonker D J, Tu D, Milano G, Graziano F, Zalcberg J, Karapetis C S, Dobrovic A, O'Callaghan C J, Liu
| From bench to bedside: Clinical implications of KRAS status in patients with colorectal liver metastasis.
Surgical oncology 2016 Sep 25 (3): 332-8.
Andreatos Nikolaos, Ronnekleiv-Kelly Sean, Margonis Georgios A, Sasaki Kazunari, Gani Faiz, Amini Neda, Wilson Ana, Pawlik Timothy
| Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy.
World journal of gastroenterology 2016 Aug 22 (30): 6944-54.
Lo Nigro Cristiana, Ricci Vincenzo, Vivenza Daniela, Granetto Cristina, Fabozzi Teresa, Miraglio Emanuela, Merlano Marco
| Efficacy of cetuximab-based chemotherapy in metastatic colorectal cancer according to RAS and BRAF mutation subgroups: A meta-analysis.
Molecular and clinical oncology 2016 Jun 4 (6): 1017-1024.
Lin L I, Chen Lu-Lu, Wang You, Meng Xiang-Yu, Liang Chen, Zhou Fu-Xia
| Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis.
Critical reviews in oncology/hematology 2016 Jan .
Passiglia Francesco, Bronte Giuseppe, Bazan Viviana, Galvano Antonio, Vincenzi Bruno, Russo Anton
| Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumours.
European journal of cancer (Oxford, England : 1990) 2016 Jan 55 122-130.
Rowland Andrew, Dias Mafalda M, Wiese Michael D, Kichenadasse Ganessan, McKinnon Ross A, Karapetis Christos S, Sorich Michael
| Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases.
The British journal of surgery 2015 Sep 102 (10): 1175-83.
Brudvik K W, Kopetz S E, Li L, Conrad C, Aloia T A, Vauthey J
| FCGR2A, FCGR3A polymorphisms and therapeutic efficacy of anti-EGFR monoclonal antibody in metastatic colorectal cancer.
Oncotarget 2015 Aug .
Ying Hou-Qun, Wang Feng, Chen Xiao-Lin, He Bang-Shun, Pan Yu-Qin, Jie Chen, Liu Xian, Cao Wei-Jun, Peng Hong-Xin, Lin Kang, Wang Shu-K
| BRAF V600E mutation as a predictive factor of anti-EGFR monoclonal antibodies therapeutic effects in metastatic colorectal cancer: a meta-analysis.
Chinese medical sciences journal = Chung-kuo i hsüeh k'o hsüeh tsa chih / Chinese Academy of Medical Sciences 2014 Dec 29 (4): 197-203.
Wang Qi, Hu Wei-guo, Song Qi-bin, Wei J
| PCR-based assays versus direct sequencing for evaluating the effect of KRAS status on anti-EGFR treatment response in colorectal cancer patients: a systematic review and meta-analysis.
PloS one 2014 9 (9): e107926.
Shan Lianfeng, Li Ming, Ma Jianzhong, Zhang Huid
| The involvement of Kras gene 3'-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis.
OncoTargets and therapy 2014 7 1487-96.
Ying Hou-Qun, Wang Feng, He Bang-Shun, Pan Yu-Qin, Gao Tian-Yi, Xu Ye-Qiong, Li Rui, Deng Qi-Wen, Sun Hui-Lin, Wang Shu-K
| Assessing the potential value of long interspersed element-1 hypomethylation in colorectal cancer: evidence from retrospective studies.
OncoTargets and therapy 0 8 3265-3276.
Tang Jie-Ting, Wang Zhen-Hua, Fang Jing-Yu
| Retraction: Evaluation and identification of factors related to KRAS and BRAF gene mutations in colorectal cancer: A meta analysis.
Journal of cancer research and therapeutics 0 13 (1): 156.
Authors are not available